Ozempic-Maker Novo Open To Upgrading Us Listing
NVO•Novo considering New York listing upgrade
- Ozempic-maker Novo is open to upgrading its New York listing.
- According to the Financial Times, Novo is open to the idea of upgrading its New York listing as part of efforts to boost the Danish weight-loss drugmaker’s profile in the US.
